Back to Search
JOHN MINNA, MD
MD
Medical Oncology Physician
NPI: 1578525556Individual
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
J2859(TX)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
J2859(TX)
Research & Publications (20)
Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer.
PMID 12511585·J Clin Invest·2003
6-review
Multifocal lung cancers--clonality vs field cancerization and does it matter?
PMID 19351914·J Natl Cancer Inst·2009
8-other
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
PMID 19582160·PLoS One·2009
8-other
Distinct biological roles for the notch ligands Jagged-1 and Jagged-2.
PMID 19398556·J Biol Chem·2009
8-other
MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.
PMID 19117057·Int J Cancer·2009
8-other
Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells.
PMID 19433257·Mol Cell Endocrinol·2009
4-observational
Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene.
PMID 19351763·Clin Cancer Res·2009
7-preclinical
SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function.
PMID 19262564·EMBO J·2009
7-preclinical
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
PMID 19238210·PLoS One·2009
8-other
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.
PMID 19451690·J Clin Invest·2009
7-preclinical
miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1.
PMID 19671678·Mol Cancer Res·2009
8-other
Histone deacetylase inhibitor romidepsin enhances anti-tumor effect of erlotinib in non-small cell lung cancer (NSCLC) cell lines.
PMID 19179890·J Thorac Oncol·2009
7-preclinical
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR.
PMID 19351834·Cancer Res·2009
8-other
Small-cell lung cancer: translational research enroute to therapeutic advances.
PMID 19227570·Oncology (Williston Park)·2008
8-other
Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops.
PMID 19138950·Cancer Prev Res (Phila)·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5323 HARRY HINES BLVD
DALLAS, TX 75390 - Phone
- (214) 645-8600
Quick Facts
- NPI
- 1578525556
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile